• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Efficacy of 3% diquafosol combined with azelastine hydrochloride in allergic conjunctivitis patients with dry eye.

作者信息

Lin Lin, Zhu Yirui, Yuan Kelan, Mou Yujie, Zhao Hanhe, Wu Yayin, Jin Xiuming

机构信息

Eye Center of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

出版信息

Adv Ophthalmol Pract Res. 2024 Feb 10;4(2):47-51. doi: 10.1016/j.aopr.2024.01.006. eCollection 2024 May-Jun.

DOI:10.1016/j.aopr.2024.01.006
PMID:38812946
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11133755/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a7/11133755/aceebdbd6b16/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a7/11133755/1732244d7ad5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a7/11133755/aceebdbd6b16/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a7/11133755/1732244d7ad5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a7/11133755/aceebdbd6b16/gr2.jpg

相似文献

1
Efficacy of 3% diquafosol combined with azelastine hydrochloride in allergic conjunctivitis patients with dry eye.3% 地夸磷索联合盐酸氮卓斯汀治疗过敏性结膜炎合并干眼患者的疗效
Adv Ophthalmol Pract Res. 2024 Feb 10;4(2):47-51. doi: 10.1016/j.aopr.2024.01.006. eCollection 2024 May-Jun.
2
Evaluation of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution and azelastine hydrochloride 0.05% ophthalmic solution in the conjunctival allergen challenge model.0.1%盐酸奥洛他定滴眼液与0.05%盐酸氮卓斯汀滴眼液在结膜过敏原激发模型中的疗效评估。
Clin Ther. 2001 Aug;23(8):1272-80. doi: 10.1016/s0149-2918(01)80106-5.
3
Comparison of the efficacy and tolerability of topically administered azelastine, sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis and rhino-conjunctivitis.局部应用氮卓斯汀、色甘酸钠及安慰剂治疗季节性变应性结膜炎和鼻结膜炎的疗效及耐受性比较。
Curr Med Res Opin. 2003;19(4):313-20. doi: 10.1185/030079903125001785.
4
Management of allergic conjunctivitis: an evaluation of the perceived comfort and therapeutic efficacy of olopatadine 0.2% and azelastine 0.05% from two prospective studies.过敏性结膜炎的管理：两项前瞻性研究对0.2%奥洛他定和0.05%氮卓斯汀的舒适度和治疗效果的评估
Clin Ophthalmol. 2009;3:329-36. doi: 10.2147/opth.s5223. Epub 2009 Jun 2.
5
Azelastine eye-drops in seasonal allergic conjunctivitis or rhinoconjunctivitis. A double-blind, randomized, placebo-controlled study.氮卓斯汀滴眼液治疗季节性变应性结膜炎或鼻结膜炎：一项双盲、随机、安慰剂对照研究
Allergy. 1998 Sep;53(9):857-62. doi: 10.1111/j.1398-9995.1998.tb03991.x.
6
Comparison of azelastine eye drops with levocabastine eye drops in the treatment of seasonal allergic conjunctivitis.氮卓斯汀滴眼液与左卡巴斯汀滴眼液治疗季节性过敏性结膜炎的比较。
Curr Med Res Opin. 2000;16(3):153-63.
7
Double-blind, randomised, placebo-controlled study of two concentrations of azelastine eye drops in seasonal allergic conjunctivitis or rhinoconjunctivitis.两种浓度氮卓斯汀滴眼液治疗季节性变应性结膜炎或鼻结膜炎的双盲、随机、安慰剂对照研究
Curr Med Res Opin. 1997;14(1):21-8. doi: 10.1185/03007999709113339.
8
Azelastine eye drops in the treatment of seasonal allergic conjunctivitis or rhinoconjunctivitis in young children.氮卓斯汀滴眼液治疗幼儿季节性过敏性结膜炎或鼻结膜炎
Curr Med Res Opin. 1998;14(3):161-70. doi: 10.1185/03007999809113356.
9
Dose-dependent protection by azelastine eye drops against pollen-induced allergic conjunctivitis. A double-blind, placebo-controlled study.
Arzneimittelforschung. 1998 Apr;48(4):379-84.
10
Topical azelastine in perennial allergic conjunctivitis.外用氮卓斯汀治疗常年性变应性结膜炎。
Curr Med Res Opin. 2003;19(4):321-9. doi: 10.1185/030079903125001794.

本文引用的文献

1
The effect of 3% diquafosol on the improvement of ocular surface post cataract surgery: A meta-analysis for time of intervention.3%地夸磷索对白内障术后眼表改善的影响：干预时间的荟萃分析
Adv Ophthalmol Pract Res. 2022 May 13;2(3):100063. doi: 10.1016/j.aopr.2022.100063. eCollection 2022 Nov-Dec.
2
[Chinese expert consensus on keratoprosthesis procedure (2021)].[角膜移植手术中国专家共识（2021年）]
Zhonghua Yan Ke Za Zhi. 2021 Oct 11;57(10):727-733. doi: 10.3760/cma.j.cn112142-20210713-00333.
3
Characterization of conjunctival microbiome dysbiosis associated with allergic conjunctivitis.
与过敏性结膜炎相关的结膜微生物群失调的特征
Allergy. 2021 Feb;76(2):596-600. doi: 10.1111/all.14635. Epub 2020 Nov 2.
4
[Paying attention to the expert consensus on dry eye to standardize and promote the clinical diagnosis and treatment of dry eye].关注干眼专家共识，规范并推进干眼临床诊疗
Zhonghua Yan Ke Za Zhi. 2020 Oct 11;56(10):726-729. doi: 10.3760/cma.j.cn112142-20200714-00476.
5
Efficacy of topical ophthalmic drugs in the treatment of dry eye disease: A systematic literature review.局部滴眼药物治疗干眼的疗效：系统文献回顾。
Ocul Surf. 2019 Jul;17(3):412-423. doi: 10.1016/j.jtos.2019.02.012. Epub 2019 Mar 4.
6
TFOS DEWS II Definition and Classification Report.TFOS DEWS II 定义与分类报告。
Ocul Surf. 2017 Jul;15(3):276-283. doi: 10.1016/j.jtos.2017.05.008. Epub 2017 Jul 20.
7
TFOS DEWS II Introduction.TFOS DEWS II 引言。
Ocul Surf. 2017 Jul;15(3):269-275. doi: 10.1016/j.jtos.2017.05.005. Epub 2017 Jul 20.
8
Increase in tear film lipid layer thickness after instillation of 3% diquafosol ophthalmic solution in healthy human eyes.滴眼 3%地夸磷索钠眼液后健康人眼的泪膜脂质层厚度增加。
Ocul Surf. 2017 Oct;15(4):730-735. doi: 10.1016/j.jtos.2017.03.005. Epub 2017 Mar 28.
9
Ocular Pharmacology of Tear Film, Dry Eye, and Allergic Conjunctivitis.泪膜、干眼及过敏性结膜炎的眼药理学
Handb Exp Pharmacol. 2017;242:97-118. doi: 10.1007/164_2016_73.
10
New Perspectives on Dry Eye Definition and Diagnosis: A Consensus Report by the Asia Dry Eye Society.干眼定义和诊断的新视角：亚洲干眼学会共识报告。
Ocul Surf. 2017 Jan;15(1):65-76. doi: 10.1016/j.jtos.2016.09.003. Epub 2016 Oct 8.